HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Byzance Daglish Selected Research

Adenocarcinoma

7/2002Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Byzance Daglish Research Topics

Disease

1Neoplasms (Cancer)
12/2014
1Adenocarcinoma
07/2002
1Anorexia
07/2002
1Stomach Neoplasms (Stomach Cancer)
07/2002

Drug/Important Bio-Agent (IBA)

2Docetaxel (Taxotere)FDA Link
12/2014 - 07/2002
1Paclitaxel (Taxol)FDA LinkGeneric
12/2014
1Carboplatin (JM8)FDA LinkGeneric
12/2014
1AC 7700IBA
12/2014
1Cisplatin (Platino)FDA LinkGeneric
12/2014

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2014
1Intravenous Infusions
07/2002